2009
DOI: 10.1093/rheumatology/kep171
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse

Abstract: In a cohort of early RA patients treated with conventional DMARDs, US-GS can detect residual disease activity more sensitively than clinical examination both in active disease and in remission. Moreover, PD-positive synovial hypertrophy identifies an ongoing inflammation even during remission and predicts short-term relapse.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
172
2
14

Year Published

2011
2011
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 281 publications
(201 citation statements)
references
References 32 publications
(53 reference statements)
13
172
2
14
Order By: Relevance
“…In assessed RA, the PD signal was previously found to be associated with structural damage (21) and with disease change on treatment with DMARDs or tumor necrosis factor blockers (22)(23)(24). PD signal was also predictive of radiographic evidence of disease progression or relapse within 6 months in RA patients in clinical remission (25,26). Our study showed PD signal as an independent risk factor of rapid disease progression during the first year of early arthritis.…”
Section: Discussionsupporting
confidence: 66%
“…In assessed RA, the PD signal was previously found to be associated with structural damage (21) and with disease change on treatment with DMARDs or tumor necrosis factor blockers (22)(23)(24). PD signal was also predictive of radiographic evidence of disease progression or relapse within 6 months in RA patients in clinical remission (25,26). Our study showed PD signal as an independent risk factor of rapid disease progression during the first year of early arthritis.…”
Section: Discussionsupporting
confidence: 66%
“…Persistent synovitis, especially in patients with early and very early RA, was proven to be present in patients being considered in clinical remission and was associated with a more unfavourable prognosis [15,22,26,32]. Analysing anti-RA33 titre, depending on US findings, we established statistically significant differences, between patients with/without active synovitis; thus, we found active synovitis only in 3 of the 15 patients with an anti-RA33 titre over the threshold value.…”
Section: Conflict Of Interest: Nonementioning
confidence: 65%
“…Setting an antibody profile, highly specific and sensitive, with a diagnostic and prognostic value, could be essential for assessing remission [1,[22][23][24][25][26]. Besides anti-CCP antibodies, present very early in the course of the disease, anti-RA33 antibodies can constitute an additional marker, not only for improving diagnosis, but also for assessing the prognosis and therapeutic response [5,27,28].…”
Section: Discussionmentioning
confidence: 99%
“…Of 3004 studies identified initially, 14 articles were selected to be included in the review 8,9,14,25,26,27,28,29,30,31,32,33,34,35 . Table 1 shows the study design characteristics of the studies.…”
Section: Journal Of Rheumatologymentioning
confidence: 99%